2019
DOI: 10.1016/j.jorganchem.2019.120918
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 74 publications
0
6
0
Order By: Relevance
“…Cell proliferation was determined by the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test, as described [ 27 ]. Briefly, THP-1 monocytes/PBMCs were seeded in 96-well plates at a density of 5 × 10 4 cells/well.…”
Section: Methodsmentioning
confidence: 99%
“…Cell proliferation was determined by the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test, as described [ 27 ]. Briefly, THP-1 monocytes/PBMCs were seeded in 96-well plates at a density of 5 × 10 4 cells/well.…”
Section: Methodsmentioning
confidence: 99%
“…For the evaluation of the anti-proliferative activity, we employed the MTT test, as previously described [ 54 , 55 ]. Briefly, SH-SY5Y cells were seeded in 96-well plates at a density of 5 × 10 3 cells/well.…”
Section: Methodsmentioning
confidence: 99%
“…12). 72 Structurally, Pt( ii ) centers and organometallic Rh( iii ) units were conjugated through a dithiooxamide ligand. Both bimetallic complexes surpassed cisplatin and the corresponding Pt( ii ) precursors in enzyme inhibition (human 20S proteasome and cathepsins) and antiproliferation.…”
Section: Dual Pharmacophore and Pt-containing Heterometallic Complexesmentioning
confidence: 99%